Showing results (91-100 of 209) with videos related to
Sort By:
Pageof 21
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 24, 2013
Feasibility and predictability of perioperative PET and estrogen receptor ligand in patients with invasive breast cancerMary L Gemignani, Sujata Patil, Venkatraman E Seshan, et al.Radiology|August 11, 2010
Recurrent ovarian cancer: use of contrast-enhanced CT and PET/CT to accurately localize tumor recurrence and to predict patients' survivalEvis Sala, Masako Kataoka, Neeta Pandit-Taskar, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 17, 2008
Antibody mass escalation study in patients with castration-resistant prostate cancer using 111In-J591: lesion detectability and dosimetric projections for 90Y radioimmunotherapyNeeta Pandit-Taskar, Joseph A O'Donoghue, Michael J Morris, et al.Clinical Nuclear Medicine|January 3, 2018
Ectopic Undescended Parathyroid Adenoma-SPECT/CT Avoids False-Negative Interpretation on 99mTc-MIBI Dual-Phase ScintigraphySonia Mahajan, Heiko SchoderEuropean Journal of Nuclear Medicine and Molecular Imaging|May 8, 2020
Comparison of 68Ga-DOTA-JR11 PET/CT with dosimetric 177Lu-satoreotide tetraxetan (177Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapySimone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 3, 2021
Tumor Response to Radiopharmaceutical Therapies: The Knowns and the UnknownsGeorge Sgouros, Yuni K Dewaraja, Freddy Escorcia, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 23, 2024
A Phase 0 Study to Assess the Biodistribution and Pharmacokinetics of a Radiolabeled Antibody Targeting Human Kallikrein 2 in Participants with Metastatic Castration-Resistant Prostate CancerNeeta Pandit-Taskar, Joseph A O'Donoghue, Dushen Chetty, et al.Gynecologic Oncology|January 11, 2011
Sentinel lymph node biopsy in the management of early-stage cervical carcinomaJohn P Diaz, Mary L Gemignani, Neeta Pandit-Taskar, et al.NPJ Precision Oncology|February 13, 2026
Complete remission of relapsed ATXN2L::JAK2 fusion positive anaplastic large cell lymphoma following ruxolitinib monotherapy in a childTal Cohen, Ting Zhou, Ukuemi Edema, et al.European Journal of Nuclear Medicine and Molecular Imaging|October 13, 2020
IntraOmmaya compartmental radioimmunotherapy using 131I-omburtamab-pharmacokinetic modeling to optimize therapeutic indexRahul S Yerrabelli, Ping He, Edward K Fung, et al.Pageof 21